CLINICAL_TRIALS
trial_result
· 2012-03-13
Clinical Trial Update: Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis [Phase 2]
Summary
Phase 2 trial update for ABI-007 in preventing vascular access graft failure in hemodialysis patients; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Hemodialysis Graft Dysfunction | Phase 2 | Status: TERMINATED | Results posted: 2012-03-13